Translational Research Outcomes at Pitt
The Coulter Program, housed at Pitt’s Swanson School of Engineering, funds translational research by clinician-bioengineer partnerships that address unmet clinical needs through innovative technologies. The University of Pittsburgh was awarded a $3.54 million grant from the Wallace H. Coulter Foundation in fall 2011 (one of only 6 such awards nationwide) which is supplemented by $1.5 million in matching funds from the University’s School of Medicine, the Swanson School of Engineering, and the Office of Technology Management. This funding is applied to novel approaches and innovative technologies to address unmet clinical needs.
Teams competing for Coulter Program funding had to participate in a four-month “From Benchtop to Bedside” course designed to give basic information necessary to assess the therapeutic or diagnostic potential of proposed translational research-based technologies. The teams are then evaluated by the Program’s oversight committee, which is comprised of clinicians experienced in translation, business leaders accomplished in medical device commercialization including regulatory affairs and reimbursement, large medical device company representatives, and local and national angel investors and venture capitalists.
To learn more information about the funded projects, from both the first and second funding cycle, please follow the respective links below.